Metabolome remodeling with reverse-engineered exclusive enteral nutrition in children with active Crohn’s disease
Inflammatory Bowel Diseases · 2026
DOI: 10.1093/ibd/izag095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von David L Suskind und 12 weiteren Autor:innen. Beteiligte Einrichtung: Inflammatory Bowel Disease Center, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Seattle Children's Ho…. Hauptthemen laut MEDLINE: Crohn Disease, Enteral Nutrition, Metabolome. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Richards Family Foundation, NIH HHS, NIDDK NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
For children with Crohn’s disease (CD), dietary therapy with exclusive enteral nutrition (EEN) is effective in achieving clinical and biochemical remission. We investigated changes in metabolites in multiple clinical sample types from children with CD following a whole foods–blended (“reverse-engineered”) EEN formula and defined associations between these changes and remission.
Methods
Stool, urine, serum, and plasma from a prospective study of newly diagnosed pediatric patients with CD enrolled in a 4-week trial of reverse-engineered exclusive enteral nutrition (RE-EEN) were analyzed using mass spectrometry targeting aqueous metabolites, bile acids, and short-chain fatty acids. Principal component analysis, mixed-effects models, and exploratory multivariate approaches including random forest and partial least-squares discriminant analysis were used to identify patterns associated with diet and metabolite abundances.
Results
Fecal, urine, serum, and plasma metabolomes changed significantly during RE-EEN treatment from baseline. These global changes were largely driven by increases in amino acids and related metabolites and decreases in different amino acids and metabolites reflecting carbohydrate and purine metabolism, in all sample types. While global bile acid profiles changed with the RE-EEN diet, no changes in specific bile acid levels reached significance, and no changes were found in short-chain fatty acid concentrations.
Conclusion
Metabolomic profiles for pediatric patients with CD changed broadly during RE-EEN, indicating that this therapy may modulate key systemic and gut-associated metabolic processes. The findings further suggest that the gut metabolic processes influenced by RE-EEN, and that contribute to clinical improvement, may differ from those impacted by commercial EEN diets. Further research is crucial to validate these findings, uncover causal relationships, and optimize dietary protocols to enhance therapeutic outcomes in CD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inflammatory Bowel Disease Center, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Seattle Children's Hospital, Seattle, WA 98105, United States.
- Department of Microbiology, University of Washington, Seattle, WA 98195, United States.
- Pythia Informatics, Ottawa, ON K1S 0S7, Canada.
- Northwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98109, United States.
ORCID-Profile: David L Suskind, Lucas R Hoffman, Danijel Djukovic, Daniel Raftery, Hillary S Hayden
Förderung
- Richards Family Foundation
- NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Suskind, D. L., Hoffman, L. R., Lee, D., Verster, A. J., Zheng, H. B., Francis, K., Nuding, M., Vanamala, J., Wahbeh, G., Purcell, H., Djukovic, D., Raftery, D., & Hayden, H. S. (2026). Metabolome remodeling with reverse-engineered exclusive enteral nutrition in children with active Crohn’s disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izag095
Vancouver
Suskind DL, Hoffman LR, Lee D, Verster AJ, Zheng HB, Francis K, et al. Metabolome remodeling with reverse-engineered exclusive enteral nutrition in children with active Crohn’s disease. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izag095
BibTeX
@article{Suskind2026,
author = {Suskind, David L and Hoffman, Lucas R and Lee, Dale and Verster, Adrian J and Zheng, Hengqi Betty and Francis, Kendra and Nuding, Mason and Vanamala, Jairam and Wahbeh, Ghassan and Purcell, Hayley and Djukovic, Danijel and Raftery, Daniel and Hayden, Hillary S},
title = {Metabolome remodeling with reverse-engineered exclusive enteral nutrition in children with active Crohn’s disease},
journal = {Inflammatory Bowel Diseases},
year = {2026},
doi = {10.1093/ibd/izag095}
}
EUVIMED